Alnylam Pharmaceuticals, Inc.

FORSTA AP-FONDEN ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

46,420

Value ($000)

18,459

Weight

0.1%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	18,459	0.1%	46,420	12/31/2025
2025 Q3	11/10/2025	12,722	0.1%	27,900	9/30/2025
2025 Q2	8/8/2025	8,609	0.1%	26,400	6/30/2025
2025 Q1	5/12/2025	6,967	0.1%	25,800	3/31/2025
2024 Q4	1/23/2025	12,895	0.1%	54,800	12/31/2024
2024 Q3	10/24/2024	13,999	0.1%	50,900	9/30/2024
2024 Q2	8/8/2024	6,124	0.1%	25,200	6/30/2024
2024 Q1	5/7/2024	10,207	0.1%	68,300	3/31/2024
2023 Q4	2/6/2024	4,364	0.0%	22,800	12/31/2023
2023 Q3	10/25/2023	4,498	0.1%	25,400	9/30/2023
2023 Q2	8/3/2023	4,730	0.1%	24,900	6/30/2023
2023 Q1	4/21/2023	5,168	0.1%	25,800	3/31/2023
2022 Q4	2/2/2023	6,797	0.1%	28,600	12/31/2022
2022 Q3	10/17/2022	4,624	0.1%	23,100	9/30/2022
2022 Q2	8/11/2022	4,230	0.1%	29,000	6/30/2022
2022 Q1	5/9/2022	3,805	0.0%	23,300	3/31/2022
2021 Q4	2/11/2022	4,036	0.0%	23,800	12/31/2021
2021 Q3	11/10/2021	4,399	0.0%	23,300	9/30/2021
2021 Q2	8/12/2021	2,272	0.0%	13,400	6/30/2021
2021 Q1	5/11/2021	3,530	0.0%	25,000	3/31/2021
2020 Q4	2/9/2021	3,041	0.0%	23,400	12/31/2020
2020 Q3	2/19/2021	2,708	0.1%	18,600	9/30/2020
2020 Q2	8/11/2020	2,148	0.1%	14,500	6/30/2020
2020 Q1	5/4/2020	1,763	0.1%	16,200	3/31/2020